We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.6B
AUM Growth
+$2.71B
Cap. Flow
+$599M
Cap. Flow %
2.91%
Top 10 Hldgs %
26.44%
Holding
1,633
New
69
Increased
616
Reduced
373
Closed
77

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$153M
2
AVGO icon
Broadcom
AVGO
+$87.4M
3
ADBE icon
Adobe
ADBE
+$71.2M
4
AAPL icon
Apple
AAPL
+$67.6M
5
CNM icon
Core & Main
CNM
+$58.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$62M
2
RGA icon
Reinsurance Group of America
RGA
+$51.5M
3
MDT icon
Medtronic
MDT
+$35.3M
4
MOH icon
Molina Healthcare
MOH
+$34.7M
5
BABA icon
Alibaba
BABA
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 32.69%
2 Healthcare 19.57%
3 Financials 10.5%
4 Industrials 10.22%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCS
1426
DELISTED
Steelcase
SCS
$268K ﹤0.01%
19,818
-1,300
-6% -$15.4K
RKT icon
1427
Rocket Companies
RKT
$39.8B
$267K ﹤0.01%
18,450
-35,536
-66% -$340K
KROS icon
1428
Keros Therapeutics
KROS
$222M
$266K ﹤0.01%
6,700
AMSF icon
1429
AMERISAFE
AMSF
$517M
$265K ﹤0.01%
5,658
+1,100
+24% +$54.9K
BFH icon
1430
Bread Financial
BFH
$4.46B
$264K ﹤0.01%
8,000
CIM
1431
Chimera Investment
CIM
$991M
$262K ﹤0.01%
17,487
HRMY icon
1432
Harmony Biosciences
HRMY
$2.32B
$262K ﹤0.01%
8,100
LGND icon
1433
Ligand Pharmaceuticals
LGND
$5.85B
$261K ﹤0.01%
3,658
CERT icon
1434
Certara
CERT
$1.22B
$260K ﹤0.01%
14,800
CWH icon
1435
Camping World
CWH
$659M
$260K ﹤0.01%
9,900
ABCL icon
1436
AbCellera Biologics
ABCL
$3.18B
$259K ﹤0.01%
45,400
+5,400
+14% +$25K
HAIN icon
1437
Hain Celestial
HAIN
$52.9M
$259K ﹤0.01%
23,639
+11,900
+101% +$128K
STEP icon
1438
StepStone Group
STEP
$3.96B
$259K ﹤0.01%
8,128
FRHC icon
1439
Freedom Holding
FRHC
$9.65B
$258K ﹤0.01%
3,200
-100
-3% -$8.15K
RC
1440
Ready Capital
RC
$289M
$258K ﹤0.01%
25,130
+11,200
+80% +$114K
SAFE
1441
Safehold
SAFE
$1.09B
$258K ﹤0.01%
11,043
+700
+7% +$13.2K
BROS icon
1442
Dutch Bros
BROS
$8.91B
$257K ﹤0.01%
+8,100
New +$221K
LU icon
1443
Lufax Holding
LU
$1.33B
$257K ﹤0.01%
83,625
APPN icon
1444
Appian
APPN
$2.49B
$256K ﹤0.01%
6,800
HMN icon
1445
Horace Mann Educators
HMN
$2.09B
$256K ﹤0.01%
7,830
ZETA icon
1446
Zeta Global
ZETA
$7.17B
$256K ﹤0.01%
29,000
-2,200
-7% -$18.5K
ELME
1447
Elme Communities
ELME
$144M
$255K ﹤0.01%
17,483
FIGS icon
1448
FIGS
FIGS
$2.4B
$255K ﹤0.01%
36,700
+13,600
+59% +$90K
LUMN icon
1449
Lumen
LUMN
$6.49B
$255K ﹤0.01%
139,400
+28,700
+26% +$40.7K
DAWN
1450
DELISTED
Day One Biopharmaceuticals
DAWN
$254K ﹤0.01%
+17,400
New +$211K

Similar funds

Handelsbanken Fonder's Q4 2023 Portfolio in Review

As of Q4 2023, Handelsbanken Fonder held 1,633 positions worth $20.6B, up 15% from $17.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Handelsbanken Fonder's Q4 2023 filing shows 69 new, 616 increased, 373 reduced and 77 closed positions. Its largest new stake was Berkshire Hathaway Class B: 437,243 shares worth $156M. The largest sale was Linde, an estimated $62M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q4 2023 buy was Berkshire Hathaway Class B: 437,243 shares worth $156M.
  • Handelsbanken Fonder added most to Broadcom in Q4 2023, an estimated $87.4M increase.
  • Handelsbanken Fonder's biggest Q4 2023 reduction was Linde, cutting an estimated $62M.
  • Handelsbanken Fonder fully exited T1 Energy in Q4 2023, selling an estimated $27.4M.
  • Handelsbanken Fonder's ten largest holdings make up 26% of its $20.6B portfolio in Q4 2023.
  • Handelsbanken Fonder opened 69 new positions and closed 77 in Q4 2023.
  • Handelsbanken Fonder's portfolio value rose 15% quarter-over-quarter to $20.6B.

Based on Handelsbanken Fonder's 13F filing for Q4 2023, filed 1 Feb 2024.